FDMDF (4DMedical) Total Payout Ratio: 0.41 (As of Jul. 09, 2026)


FDMDF 4DMedical Ltd FDMDF
46 GF Score
Price $2.80
GF Value $0.87
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is 4DMedical Total Payout Ratio?

4DMedical FDMDF -6.67% 46 Total Payout Ratio is 0.41 as of Jul. 09, 2026. GuruFocus rates FDMDF with a GF Score™ of 46/100 and a GF Value™ of $0.87 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

4DMedical's current Total Payout Ratio is 0.41.

4DMedical Total Payout Ratio Related Terms

4DMedical Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for 4DMedical's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4DMedical Total Payout Ratio Chart

4DMedical Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Payout Ratio
Get a 7-Day Free Trial 4.18 0.00 1.35 0.97 0.44

4DMedical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.11 0.10 0.04 1.28 0.35

FDMDF vs ABT, SYK, MDT: Total Payout Ratio Comparison

For the Medical Devices subindustry, 4DMedical's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4DMedical Total Payout Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where 4DMedical's Total Payout Ratio falls into.


FDMDF
46GF Score
4DMedical Ltd FDMDF
Total Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4DMedical Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

4DMedical's Total Payout Ratio for the fiscal year that ended in Jun. 2025 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0.886 + 9.572 + 0) / -19.577
=0.44

4DMedical's Total Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0.3 + 36.196 + 0) / -102.419
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Ratio →
What does a Total Payout Ratio of 0.41 mean?
4DMedical (FDMDF) has a Total Payout Ratio of 0.41 as of Jul. 09, 2026. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on 4DMedical and its competitors.
Is 4DMedical's Total Payout Ratio too high?
4DMedical's current Total Payout Ratio is 0.41. Overall, 4DMedical has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's Total Payout Ratio compare to ABT and SYK?
4DMedical's Total Payout Ratio of 0.41 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Ratio for a Medical Devices & Instruments company?
A good Total Payout Ratio depends on the Medical Devices & Instruments industry context. However, Total Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Ratio mean?
A high Total Payout Ratio can signal that a stock is expensive relative to its fundamentals. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on 4DMedical and its competitors. 4DMedical's current Total Payout Ratio is 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (FDMDF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.87, compared to a current price of $2.80 — trading 221.8% above its estimated fair value. The current Total Payout Ratio is 0.41. 4DMedical's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Ratio calculated?
Total Payout Ratio is calculated from a company's financial statements. For 4DMedical (FDMDF), the current Total Payout Ratio is 0.41 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 4DMedical (FDMDF) Overvalued in 2026?

Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued. The current stock price of $2.80 is trading 221.8% above its estimated GF Value™ of $0.87. GuruFocus considers 4DMedical to be Significantly Overvalued.

Key valuation signals for FDMDF:

  • Total Payout Ratio: 0.41
  • GF Value™: $0.87 vs. price of $2.80 (221.8% above fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the FDMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

4DMedical Business Description

Other Exchanges MQ7:Germany4DX:Australia
Address 700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
46GF Score

Get the complete analysis for FDMDF

Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.80
Price
$0.87
GF Value